Real-time enrollment status for this chronic spontaneous urticaria clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:02 PM UTC
| NCT Number | NCT06868212 |
| Recruiting Status | Recruiting |
| Condition | Chronic Spontaneous Urticaria |
| Phase | PHASE3 |
| Target Enrollment | 400 participants |
| Active Locations | 130 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT06868212 is currently recruiting participants. This phase3 study for chronic spontaneous urticaria is actively seeking new participants at 130 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06868212 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 130 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06868212 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.